Active SLE patients (SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) score ≥5) exhibited significantly higher serum levels of IL-36α and IL-36γ than the inactive patients (SLEDAI score ≤4). The gene discussed is IL36A; the disease is systemic lupus erythematosus.